EXAS EXACT SCIENCES CORP

Nasdaq exactsciences.com


$ 68.41 $ 2.61 (3.9 %)    

Tuesday, 04-Nov-2025 17:42:04 EST
QQQ $ 615.11 $ -4.04 (-0.65 %)
DIA $ 470.25 $ 0.57 (0.12 %)
SPY $ 672.36 $ -0.79 (-0.12 %)
TLT $ 90.13 $ 0.15 (0.17 %)
GLD $ 362.19 $ -1.27 (-0.35 %)
$ 69.59
$ 70.08
$ 68.41 x 30
$ 71.20 x 100
$ 67.61 - $ 72.81
$ 38.81 - $ 72.83
8,899,965
na
13.19B
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-01-2025 03-31-2025 10-Q
4 02-19-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 07-31-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 11-01-2023 09-30-2023 10-Q
10 08-01-2023 06-30-2023 10-Q
11 05-09-2023 03-31-2023 10-Q
12 02-21-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-02-2022 06-30-2022 10-Q
15 04-26-2022 03-31-2022 10-Q
16 02-22-2022 12-31-2021 10-K
17 11-02-2021 09-30-2021 10-Q
18 07-28-2021 06-30-2021 10-Q
19 05-04-2021 03-31-2021 10-Q
20 02-16-2021 12-31-2020 10-K
21 10-27-2020 09-30-2020 10-Q
22 07-31-2020 06-30-2020 10-Q
23 05-06-2020 03-31-2020 10-Q
24 02-21-2020 12-31-2019 10-K
25 10-30-2019 09-30-2019 10-Q
26 07-30-2019 06-30-2019 10-Q
27 04-30-2019 03-31-2019 10-Q
28 02-21-2019 12-31-2018 10-K
29 10-30-2018 09-30-2018 10-Q
30 08-01-2018 06-30-2018 10-Q
31 04-26-2018 03-31-2018 10-Q
32 02-22-2018 12-31-2017 10-K
33 10-30-2017 09-30-2017 10-Q
34 07-25-2017 06-30-2017 10-Q
35 04-27-2017 03-31-2017 10-Q
36 02-21-2017 12-31-2016 10-K
37 10-26-2016 09-30-2016 10-Q
38 07-26-2016 06-30-2016 10-Q
39 05-03-2016 03-31-2016 10-Q
40 02-24-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

 td-cowen-maintains-buy-on-exact-sciences-raises-price-target-to-90

TD Cowen analyst Dan Brennan maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $74 to $90.

 palantir-weighs-on-wall-street-bitcoin-slumps-5-whats-moving-markets-tuesday

Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, o...

 baird-maintains-outperform-on-exact-sciences-raises-price-target-to-88

Baird analyst Catherine Schulte maintains Exact Sciences (NASDAQ:EXAS) with a Outperform and raises the price target from $7...

 benchmark-maintains-buy-on-exact-sciences-raises-price-target-to-75

Benchmark analyst Bruce D. Jackson maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $60 to...

 guggenheim-maintains-buy-on-exact-sciences-raises-price-target-to-75

Guggenheim analyst Subbu Nambi maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $70 to $75.

 barclays-maintains-overweight-on-exact-sciences-raises-price-target-to-77

Barclays analyst Luke Sergott maintains Exact Sciences (NASDAQ:EXAS) with a Overweight and raises the price target from $65 ...

 stifel-maintains-buy-on-exact-sciences-raises-price-target-to-80

Stifel analyst Daniel Arias maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $67 to $80.

 btig-maintains-buy-on-exact-sciences-raises-price-target-to-85

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $75 to $85.

 correction-exact-sciences-q3-adj-eps-024-beats-007-estimate-sales-850739m-beat-810178m-estimate

Exact Sciences (NASDAQ:EXAS) reported quarterly earnings of $0.24 per share which beat the analyst consensus estimate of $(0.07...

 exact-sciences-raises-fy2025-sales-guidance-from-3130b-3170b-to-3220b-3235b-vs-3156b-est

2025 outlookThe Company has updated its full-year 2025 revenue and adjusted EBITDA guidance: Prior guidance November 3 update C...

 nvidia-amazon-extend-rally-bitcoin-sinks-to-107000-whats-moving-markets-monday

Wall Street opened the week on a mixed note on Monday.

 earnings-preview-exact-sciences
Earnings Preview: Exact Sciences
10/31/2025 15:01:30

 exact-sciences-showcases-new-data-highlighting-cologuards-success-in-boosting-cancer-screening-rates

Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced new data being...

 btig-maintains-buy-on-exact-sciences-raises-price-target-to-75

BTIG analyst Mark Massaro maintains Exact Sciences (NASDAQ:EXAS) with a Buy and raises the price target from $60 to $75.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION